COSMO Pharmaceuticals Aktie
| 66,50EUR | -0,50EUR | -0,75% |
WKN DE: A2AJ68 / ISIN: NL0011832936
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 44,21 |
| Mauro Severino Ajani | 34,98 |
| Gerald Herz | 8,51 |
| Cosmo Pharmaceuticals NV | 8,50 |
| dievini Hopp BioTech holding GmbH & Co. KG | 3,80 |
| UBS Asset Management Switzerland AG | 2,99 |
| Government Pension Fund - Global (The) | 1,24 |
| Vanguard Total International Stock Index Fund | 0,75 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 234 | 265 | 290 | 295 | 325 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,30 | 0,25 | 0,24 | 0,35 | 0,28 |
Bilanz (in Mio. CHF) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 329 | 273 | 286 | 302 | 95 |
| Summe Anlagevermögen | 307 | 371 | 549 | 448 | 420 |
| Summe Aktiva | 636 | 645 | 835 | 750 | 515 |
Bilanz (in Mio. CHF) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 179 | 189 | 183 | 178 | 2 |
| Summe Fremdkapital | 208 | 220 | 311 | 299 | 116 |
| Summe Eigenkapital | 428 | 425 | 524 | 451 | 399 |
| Summe Passiva | 636 | 645 | 835 | 750 | 515 |
Adresse
| Riverside II, 2 Dublin | |
| Telefon | +353 (1) 8170370 |
| Fax | +353 (1) 8230718 |
| Internet | http://www.cosmopharma.com |
Management
|
Alessandro Della Chà
Chairman |
|
Davide Malavasi
Director-Qualified Person & Technical |
|
Diana Harbort
President-Dermatology |
|
Egle Gedrimaite
Head-Global Business Development |
|
Giovanni di Napoli
Chief Executive Officer & Executive Director |
|
Giulio Evangelisti
Senior VP-Manufacturing, Service & Security |
|
Hazel Winchester
Head-Investor Relations |
|
John O'Dea
Non-Executive Director |
|
Luigi Longo
Chief Scientific Office |
|
Marco Lecchi
Chief Operating Officer |
|
Maria Grazia Roncarolo
Independent Non-Executive Director |
|
Mauro Severino Ajani
Non-Executive Director |
|
Nhan Ngo Dinh
President-Cosmo Intelligent Medical Devices |
|
Niall Donnelly
Executive Director & Chief Sustainability Officer |
|
Paolo Lanzarotti
Manager-R&D Analytical Development |
|
Roberto Villa
Chief Manufacturing Officer |
|
Silvana Perretta
Non-Executive Director |
|
Svetlana Sigalova
Chief Financial Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
